Oestrogel (Estradiol)

Estradiol, the active ingredient in Oestrogel, is an estrogen hormone presented as a transdermal gel for topical use. It is employed to replace deficient estrogen in women undergoing menopause or other hypo‑estrogenic conditions. The gel is applied to clean, dry skin once daily, providing steady systemic absorption.

GNH USA supplies Oestrogel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple regions.

Estradiol in Oestrogel acts on estrogen‑dependent pathways to restore hormonal balance in several clinical scenarios. - Menopausal symptoms: alleviates hot flashes, night sweats, vaginal dryness, and helps maintain bone density in postmenopausal women. - Hypoestrogenism due to ovarian failure or surgical oophorectomy: restores systemic estrogen levels to reduce vasomotor symptoms and support uterine health. - Male-to-female transgender hormone therapy: provides the estrogen component necessary for feminization, including breast development and redistribution of body fat. - Prevention of postmenopausal osteoporosis: maintains bone remodeling balance, reducing the risk of fractures in women with low estrogen.

Topical estradiol may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Skin irritation at the application site: redness, itching, or rash where the gel is applied. - Nausea or mild gastrointestinal discomfort. - Headache or dizziness. - Breast tenderness or swelling.

Serious or Rare Side Effects: - Deep vein thrombosis (DVT): formation of blood clots in deep veins. - Pulmonary embolism: blockage of pulmonary arteries by a clot. - Stroke: cerebrovascular accident due to clot formation. - Hormone‑sensitive cancer progression: potential stimulation of breast or endometrial cancer.

Before initiating Oestrogel therapy, healthcare professionals should evaluate several safety considerations. - Assess cardiovascular risk: review history of thromboembolic events, hypertension, or smoking. - Screen for hormone‑sensitive malignancies: perform breast and endometrial cancer assessments. - Monitor liver function: adjust therapy in patients with hepatic impairment. - Contraindicate in pregnancy: estradiol can cause fetal harm and is not indicated. - Use lowest effective dose in elderly: start with reduced application area to limit exposure. - Store at room temperature: keep in original container, protect from light and moisture.

Estradiol may interact with several medications, altering efficacy or safety profiles.

Major Interactions (Avoid): - Combined estrogen‑containing oral contraceptives: increased risk of thromboembolic events. - Anticoagulants (e.g., warfarin): estradiol may reduce anticoagulant effect, requiring monitoring. - Selective serotonin reuptake inhibitors (SSRIs): may enhance nausea and affect estradiol metabolism. - Gonadotropin‑releasing hormone (GnRH) agonists: may reduce estradiol efficacy.

Moderate Interactions (Monitor Closely): - Tamoxifen: antagonistic action may diminish tamoxifen’s anti‑cancer effect. - Thyroid hormone replacement: estradiol can increase thyroid‑binding globulin, altering levothyroxine levels. - Antihypertensive agents: estrogen may potentiate blood pressure‑lowering effects. - Cytochrome P450 inhibitors (e.g., ketoconazole): may increase estradiol plasma levels.